Results 141 to 150 of about 14,896 (211)

Clinical Impact of Febuxostat in HFpEF Versus HFrEF: Insights from a Prospective Cohort. [PDF]

Balkan Med J
Ahsaan F, Latif B, Rehman Z.
europepmc   +1 more source

The Use of Single Dose of Rasburicase for the Prophylaxis and Treatment of Tumor Lysis Syndrome in Pediatric Patients: A Narrative Review. [PDF]

Hematol Rep
Lee AC.
europepmc   +1 more source

Serum Uric Acid as a Mediator of Insulin Resistance: Molecular Mechanisms and Metabolic Pathways. [PDF]

Endocrinol Diabetes Metab
Ali N.
europepmc   +1 more source

Guideline adherence of xanthine oxidase inhibitor utilization to treat gout in primary care. [PDF]

J Manag Care Spec Pharm
Claus LW, Auten ME, Saseen JJ, Billups SJ.   +3 more
europepmc   +1 more source

Strategies to reduce uric acid through gut microbiota intervention. [PDF]

Front Microbiol
Cui Y, An P, Li F, Duan F, Mei Z, Ye Q, Wang G, Zhang H, Luo Y.   +8 more
europepmc   +1 more source

Hyperuricemia-induced kidney injury: a narrative review of mechanisms and therapeutic advances. [PDF]

BMC Nephrol
Zhang Y, He F, Yu X, Li T, Zhou L, Shen B.   +5 more
europepmc   +1 more source

Guiling prescription attenuates hyperuricemia via multi-target regulation of uric acid metabolism, renal protection, and inflammation: insights from metabolomics and network pharmacology. [PDF]

Front Nutr
Wang Y, Ding R, Guo Y, Zhou T, Zhao H, Liu H, Qin X, Gao X.   +7 more
europepmc   +1 more source

Dose-Sparing Efficacy of d-Limonene with Low-Dose Allopurinol in a Dual Model of Hyperuricemia and Gouty Arthritis in Rats. [PDF]

Nutrients
Venkatesan K, Muralidharan P, Sivadasan D, Pichaivel M, Asiri YI, Asseri KA, Sirag N, Elfadil H, Elodemi M, Prabahar K, Paulsamy P, Chidambaram K.   +11 more
europepmc   +1 more source

Benzbromarone Inhibits Renal URAT1 and Attenuates Renal Damage in Streptozotocin-Induced Diabetic Rats, Independent of Its Uricosuric Effects. [PDF]

J Diabetes Res
Chen C, Zhu P, Tan R, Liu Y, Ran J.
europepmc   +1 more source